BioCryst

+$0.37 (+3.05%) As of 6:12 PM UTC today

Why Robinhood?

You can buy or sell BioCryst and other stocks, options, and ETFs commission-free!

About BCRX

BioCryst Pharmaceuticals, Inc. Common Stock, also called BioCryst, is a commercial-stage biotechnology company, which engages in the development and discovery of novel, oral, and small-molecule medicines.

CEO
Jon P. Stonehouse
Employees
246
Headquarters
Durham, North Carolina
Founded
1986

BCRX Key Statistics

Market Cap
2.44B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
4.95M
High Today
$12.67
Low Today
$11.90
Open Price
$12.09
Volume
2.30M
52 Week High
$14.24
52 Week Low
$3.30

BCRX News

BenzingaMay 6

Why BioCryst Pharmaceuticals' Stock Is Trading Higher Today - BioCryst Pharmaceuticals

BioCryst Pharmaceuticals (NASDAQ:BCRX) shares are trading higher after the company reported better-than-expected Q1 sales results. BioCryst Pharmaceuticals' st

BCRX Earnings

-$0.36
-$0.24
-$0.12
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.27 per share
Actual
-$0.36 per share
Replay Earnings Call

You May Also Like

AAME
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure